CLPT Q4 2022 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$340M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+20.8% YoY

Gross Profit

$3M64.1% margin

Operating Income

-$4M-86.4% margin

Net Income

-$4M-84.8% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+0.5%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$55M

Total Liabilities

$19M

Stockholders' Equity

$37M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+20.8%
Gross Profit	$3M	$3M	+0.8%
Operating Income	-$4M	-$4M	-12.2%
Net Income	-$4M	-$4M	-5.7%

Revenue Segments

Functional Neurosurgery Navigation and Therapy

$2M50%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M41%

Functional Neurosurgery Navigation and Therapy - Services

$412,0009%